BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2652542)

  • 1. Donor source, number of transplants, age at transplant, and diabetes: risk factors in the cyclosporine era.
    Fryd DS; Kruse LV; Simmons RL; Sutherland DE; Payne WD; Najarian JS
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1655-6. PubMed ID: 2652542
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of diabetes mellitus on transplantation.
    Waki K
    Clin Transpl; 2004; ():357-77. PubMed ID: 16704163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of donor and recipient risk factors on pancreas transplant outcome.
    Gruessner RW; Troppmann C; Barrou B; Dunn DL; Moudry-Munns KC; Najarian JS; Sutherland DE; Gruessner AC
    Transplant Proc; 1994 Apr; 26(2):437-8. PubMed ID: 8171491
    [No Abstract]   [Full Text] [Related]  

  • 4. Kidney retransplantation in the cyclosporine era.
    Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of original disease on long-term outcome of cadaver kidney transplant. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1996 Jun; 28(3):1148-9. PubMed ID: 8658603
    [No Abstract]   [Full Text] [Related]  

  • 7. Multivariate analysis of factors affecting patient and graft survival after renal transplant.
    Orsenigo E; Socci C; Carlucci M; Zuber V; Fiorina P; Gavazzi F; Secchi A; Di Carlo V; Staudacher C
    Transplant Proc; 2005; 37(6):2461-3. PubMed ID: 16182709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation.
    Bordes-Aznar J; Odor A; Dib-Kuri A; Gabilondo F; Kasep J; Peña JC; Herrera-Acosta J; Chávez-Peón F
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080
    [No Abstract]   [Full Text] [Related]  

  • 9. Superior results of well matched cadaveric grafts as compared to parental grafts.
    Ascher NL; Simmons RL; Fryd DS; Najarian JS
    Proc Clin Dial Transplant Forum; 1977; 7():11-7. PubMed ID: 356030
    [No Abstract]   [Full Text] [Related]  

  • 10. Recipient and donor sex.
    Yuge J
    Clin Transpl; 1988; ():339-44. PubMed ID: 3154483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract]   [Full Text] [Related]  

  • 12. Living donor kidney transplants.
    Cicciarelli J
    Clin Transpl; 1988; ():293-9. PubMed ID: 3154482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in kidney transplantation outcome: the Andalusian Kidney Transplant Registry, 1984-2007.
    Gentil Govantes MA; Rodriguez-Benot A; Sola E; Osuna A; Mazuecos A; Bedoya R; Borrego J; Muñoz-Terol JM; Castro P; Alonso M
    Transplant Proc; 2009 Jun; 41(5):1583-5. PubMed ID: 19545684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World transplant records--1996. Patients who currently have functioning transplants.
    Clin Transpl; 1996; ():459-517. PubMed ID: 9286588
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term results with single pediatric donor kidney transplants in adult recipients.
    Modlin C; Novick AC; Goormastic M; Hodge E; Mastrioanni B; Myles J
    J Urol; 1996 Sep; 156(3):890-5. PubMed ID: 8709356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefits of kidney transplantation with expanded criteria deceased donors in patients aged 60 years and over.
    Savoye E; Tamarelle D; Chalem Y; Rebibou JM; Tuppin P
    Transplantation; 2007 Dec; 84(12):1618-24. PubMed ID: 18165773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal regrafts.
    Imagawa DK; Cecka JM
    Clin Transpl; 1988; ():387-98. PubMed ID: 3154489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era?
    Brayman KL; Egidi MF; Naji A; Friedman AL; Holland MT; Tomaszewski JE; Samini F; Perloff J; Grossman R; Barker CF
    Transplant Proc; 1994 Oct; 26(5):2525-7. PubMed ID: 7940776
    [No Abstract]   [Full Text] [Related]  

  • 19. Living related donor kidney grafts in the cyclosporine era.
    MacDonald AS; Belitsky P; Bitter-Suermann H; Cohen A; Crocker J; Ogborn M
    Transplant Proc; 1989 Apr; 21(2):3364-5. PubMed ID: 2652839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreas transplantation at the University of Wisconsin.
    Odorico JS; Leverson GE; Becker YT; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
    Clin Transpl; 1999; ():199-210. PubMed ID: 11038638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.